MyFinsight
Home
Blog
About
Maturities of marketable
securities
$108,807K
(-52.51%↓ Y/Y)
Exercise of stock options
$2,294K
(-8.02%↓ Y/Y)
Proceeds from employee
stock purchase plan
$793K
(32.61%↑ Y/Y)
Sales of marketable
securities
$22,800K
(-41.01%↓ Y/Y)
Net cash provided by
(used in) investing...
$78,490K
(166.37%↑ Y/Y)
Net cash provided by
financing activities
$3,087K
(-98.38%↓ Y/Y)
Canceled cashflow
$53,117K
Net change in cash
and cash...
$39,108K
(2150.17%↑ Y/Y)
Canceled cashflow
$42,469K
Purchases of marketable
securities
$53,085K
(-86.25%↓ Y/Y)
Purchases of property and
equipment
$32K
(-65.96%↓ Y/Y)
Stock-based compensation
$9,362K
(-44.25%↓ Y/Y)
Accrued compensation
$2,898K
(165.57%↑ Y/Y)
Accrued other expenses
and other...
$2,811K
(317.40%↑ Y/Y)
Accounts payable
$781K
(-71.15%↓ Y/Y)
Depreciation
$541K
(-45.90%↓ Y/Y)
Amortization of right-of-use
asset
$56K
(-34.12%↓ Y/Y)
Net cash used in
operating activities
-$42,469K
(39.72%↑ Y/Y)
Canceled cashflow
$16,449K
Net loss
-$57,327K
(25.47%↑ Y/Y)
Accretion of discount on
marketable securities, net
$809K
(-80.39%↓ Y/Y)
Prepaid expenses and
other assets
$579K
(-85.34%↓ Y/Y)
Lease liability
-$203K
(44.54%↑ Y/Y)
Back
Back
Cash Flow
Edgewise Therapeutics, Inc. (EWTX)
Edgewise Therapeutics, Inc. (EWTX)
source: myfinsight.com